1-5 of 5
Christopher Watt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome

Qian Zhang, Elena J. Orlando, Hong Y. Wang, Agata M. Bogusz, Xiaobin Liu, Simon F. Lacey, Honore T. Strauser, Selene Nunez-Cruz, Reza Nejati, Paul Zhang, Sarah Brooks, Christopher Watt, J. Joseph Melenhorst, Carl H. June, Stephen J. Schuster, Mariusz A. Wasik
Journal: Blood
Blood (2020) 136 (17): 1980–1983.
https://doi.org/10.1182/blood.2020005123
Published: 2020
Includes: Supplemental data
Journal Articles

Mechanisms of Acquired Resistance to Gilteritinib Therapy in Relapsed and Refractory FLT3 -Mutated Acute Myeloid Leukemia

Christine M. McMahon, MD, Jonathan Canaani, MD, Bryan Rea, MD, Rachel Lynn Sargent, MD, Jennifer J.D. Morrissette, PhD, David B. Lieberman, MS, CGC, Christopher Watt, MD PhD, Gregory W. Schwartz, PhD, Robert B. Faryabi, PhD, Timothy T. Ferng, MD, Neil P. Shah, MD PhD, Catherine C. Smith, MD, Martin Carroll, MD, Alexander E. Perl, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 295.
https://doi.org/10.1182/blood.V130.Suppl_1.295.295
Published: 2017
Journal Articles

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding

Clinical Trials & Observations Brief Report
Sarah K. Westbury, Matthias Canault, Daniel Greene, Emilse Bermejo, Katharine Hanlon, Michele P. Lambert, Carolyn M. Millar, Paquita Nurden, Samya G. Obaji, Shoshana Revel-Vilk, Chris Van Geet, Kate Downes, Sofia Papadia, Salih Tuna, Christopher Watt, NIHR BioResource–Rare Diseases Consortium, Kathleen Freson, Michael A. Laffan, Willem H. Ouwehand, Marie-Christine Alessi, Ernest Turro, Andrew D. Mumford
Journal: Blood
Blood (2017) 130 (8): 1026–1030.
https://doi.org/10.1182/blood-2017-03-776773
Published: 2017
Includes: Supplemental data
Journal Articles

Diverse Histopathologic and Molecular Responses of Acute Myeloid Leukemia to the FLT3 Inhibitor Quizartinib (AC220)

Grant E Nybakken, MD, PhD, Christopher Watt, MD, PhD, Jennifer JD Morrissette, PhD, Adam Bagg, MD, Martin Carroll, MD, Alexander E Perl, MD
Journal: Blood
Blood (2012) 120 (21): 885.
https://doi.org/10.1182/blood.V120.21.885.885
Published: 2012
Journal Articles

Results of An International Study of Quantitative BCR/ABL Assays Using Defined RNA Samples

Dorie A. Sher, BS, Jeffrey E. Miller, PhD, Qi Wei, BS, Jerald P. Radich, MD, Chris L.P. Wong, PhD, Iris Schrijver, MD, B. Kelly McNeil, BS, Elisa Romeo, PhD, Eric Winstall, PhD, Lurdes Zamora, PhD, Claire Abbal, PhD, Katrien Pieters, PhD, Dolors Colomer, MD, PhD, Brigitte Maes, MD, PhD, Phillippe Van Lint, PhD, Pierre JJC DeSchouwer, MD, Marleen Bakkus, PhD, Celine Callens, PhD, Barbara Denys, PhD, Nancy Boeckx, MD, Peter Vandenberghe, MD, PhD, Freya Vaeyens, MS, Hongxin Fan, MD, Sherry Taylor, PhD, George Georgiou, MD, Thomas J. Monroe, PhD, Kimberly Hocker, BS, Teresa Webb-Martin, MS, Heather Todd, MS, Adriana Muniz-Fernandez, PhD, Hanfang Zhang, MD, PhD, Petr Starostik, MD, C. Renee Webb, BS, Li Cai, PhD, Christopher Watt, MD, PhD, Linda Fletcher, BS, Suzan Lambin, PhD, Oscar Fuster, PhD, Ying Huang, PhD, Jay H. Shaw, PhD
Journal: Blood
Blood (2010) 116 (21): 2742.
https://doi.org/10.1182/blood.V116.21.2742.2742
Published: 2010